Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Synlogic Inc (NQ: SYBX )

0.5811 +0.0060 (+1.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,352
Open 0.5900
Bid (Size) 0.5710 (1)
Ask (Size) 0.6056 (3)
Prev. Close 0.5751
Today's Range 0.5750 - 0.6086
52wk Range 0.5500 - 2.600
Shares Outstanding 70,519,940
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
Presentations included full data from both the Phase 2 Synpheny-1 Study in phenylketonuria and Phase 1 Study for SYNB1353 as a potential treatment for homocystinuria 
From Synlogic, Inc.
Via Globe NewsWire
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via Globe NewsWire

Performance

YTD
-21.63%
-21.63%
1 Month
-21.47%
-21.47%
3 Month
-20.94%
-20.94%
6 Month
-37.02%
-37.02%
1 Year
-76.28%
-76.28%

More News

Read More
Synlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference
From Synlogic, Inc.
Via Globe NewsWire
Synlogic Touts Positive Data From Rare Inherited Disorder Trial, Pivotal Study To Start Next Year
Via Benzinga
Life Sciences Virtual Investor Forum Agenda Announced for March 9th
From Virtual Investor Conferences
Via Globe NewsWire
Synlogic To Present Three Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
From Synlogic, Inc.
Via Globe NewsWire
Synlogic Announces Participation in Upcoming Investor and Industry Conferences
From Synlogic, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Synlogic Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria (PKU)
From Synlogic, Inc.
Via Globe NewsWire
Sidoti's January Micro-Cap Conference
Via ACCESSWIRE
Synlogic Provides Corporate Update and Outlook for 2023
From Synlogic, Inc.
Via Globe NewsWire
Synlogic Announces Appointment of Dr. Dave Hava as Head of Research and Development
From Synlogic, Inc.
Via Globe NewsWire
Synlogic's Experimental Drug Lowers Urinary Oxalate In Gastric Bypass Patients
Via Benzinga
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
From Synlogic, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update
From Synlogic, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
BP To Rally Around 22%? Plus This Analyst Predicts $47 For YETI
Via Benzinga
Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update
From Synlogic, Inc.
Via Globe NewsWire
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
From Synlogic, Inc.
Via Globe NewsWire
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.